Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Abeona Therapeutics Inc shares valued at $119,500 were sold by Seshadri Vishwas on Mar 31 ’25. At $4.78 per share, Seshadri Vishwas sold 25,000 shares. The insider’s holdings dropped to 1,355,322 shares worth approximately $7.31 million following the completion of this transaction.
Also, Seshadri Vishwas purchased 25,000 shares, netting a total of over 119,560 in proceeds.
Before that, Alvino Mark had sold 4,000 shares from its account. In a trade valued at $21,520, the Director traded Abeona Therapeutics Inc shares for $5.38 each. Upon closing the transaction, the insider’s holdings decreased to 4,000 shares, worth approximately $0.35 million.
As published in their initiating research note from Oppenheimer on March 05, 2025, Abeona Therapeutics Inc [ABEO] has been an Outperform and the price target has been revised to $16. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early July. As of May 30, 2024, Stifel has initiated its “Buy” rating for ABEO. Earlier on November 11, 2020, Cantor Fitzgerald upgraded its rating. Their new recommendation was “an Overweight” for ABEO stock which previously was a “a Neutral”.
Analyzing ABEO Stock Performance
During the last five days, there has been a surge of approximately 11.13%. Over the course of the year, Abeona Therapeutics Inc shares have dropped approximately -3.23%. Shares of the company reached a 52-week high of $6.16 on 02/14/25 and a 52-week low of $3.93 on 04/09/25. A 50-day SMA is recorded $5.14, while a 200-day SMA reached $5.57.
Support And Resistance Levels for Abeona Therapeutics Inc (ABEO)
According to the 24-hour chart, there is a support level at 5.21, which, if violated, would cause prices to drop to 5.03. In the upper region, resistance lies at 5.56. The next price resistance is at 5.72. RSI (Relative Strength Index) is 60.80 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.52, which suggests the price will decrease in the coming days. Percent R is at 16.57%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
